Hub71+ Life Sciences marks first year establishing Abu Dhabi as a destination for global healthcare innovation

Résumé détaillé

In its first year, Hub71+ Life Sciences built a portfolio of 58 startups that have collectively raised USD 463 million (AED 1.7 billion) ...

Abu Dhabi, UAE – Hub71, Abu Dhabi's global tech ecosystem is marking the first anniversary of Hub71+ Life Sciences, with the specialist ecosystem establishing Abu Dhabi as a growing destination where health and life sciences startups choose to build, validate and scale. Established in collaboration with the Department of Health – Abu Dhabi (DoH), the Emirates Drug Establishment (EDE) and the Health, Endurance, Longevity and Medicine (HELM) cluster, Hub71+ Life Sciences is strengthening the connections between scientific research, clinical development and commercial application, contributing to Abu Dhabi's economic growth and its ambition to become a global hub for life sciences innovation.

In its first year, Hub71+ Life Sciences built a portfolio of 58 startups that have collectively raised USD 463 million (AED 1.7 billion) in funding and generated USD 138 million (AED 506.8 million) in revenue. Building on this momentum, the ecosystem has also expanded its network to 15 strategic partners, including recent collaborations with Johnson & Johnson and Mediclinic Middle East, strengthening access to clinical expertise and creating further opportunities for startups to develop their technologies and explore commercial applications.

Life sciences is a priority sector for Abu Dhabi, with investments in healthcare research, biotechnology and medical technologies supporting the emirate’s economic diversification ambitions. Initiatives such as the Health, Endurance, Longevity and Medicine (HELM) cluster, which is projected to contribute AED 94 billion to Abu Dhabi's GDP by 2045, reflect the scale of this ambition. As the emirate expands its capabilities, connecting healthcare providers and research institutions with emerging technologies is essential to advancing clinical research and commercial outcomes.

Basma AlBadi AlDhaheri, Head of Growth and Value Creation at Hub71, said: "Abu Dhabi's strong healthcare infrastructure, progressive regulatory environment and growing network…

Début de l'article, extrait de Zawya. Pour lire la suite, ouvrez l'article chez le média.